Audiologists in Muskogee, OK Accepting Medicare
5 Audiologists found. Showing 1 - 5
 Dr. Traci Lee Wilkerson, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3312 W Okmulgee St, Muskogee, OK 74401 Phone: 918-682-1515 Fax: 918-682-1598 |
Marcia Elaine Woodard, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1011 Honor Heights Dr, Muskogee, OK 74401 Phone: 918-683-3261 Fax: 918-680-3677 |
 Kenneth W. Owens, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1011 Honor Heights Dr, Muskogee, OK 74401 Phone: 918-683-3261 Fax: 918-680-3677 |
 Traci L Wilkerson Aud Inc Pc Audiologist Medicare: Medicare Enrolled Practice Location: 3312 W Okmulgee St, Muskogee, OK 74401 Phone: 918-682-1515 Fax: 918-682-1598 |
Mrs. Mary Ellen Finerty, M.A. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3401 River Oaks Dr, Muskogee, OK 74403 Phone: 918-616-1862 |
News Archive
New 3D cell culture system could facilitate search for therapeutic agents for Parkinson's disease
The progressive loss of neurons in the brain of Parkinson's patients is slow yet inexorable. So far, there are no drugs that can halt this insidious process.
Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy
Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.
EMA validates Lux Biosciences' voclosporin MAA
Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.
Mallinckrodt Study Shows Acthar® Reduces Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus
Data presented yesterday by researchers for Mallinckrodt plc, a leading specialty biopharmaceutical company, suggest that H.P. Acthar® Gel (repository corticotropin injection) reduces certain measures of disease activity in patients with persistently active Systemic Lupus Erythematosus (SLE) who are receiving corticosteroid therapy.
› Verified 1 days ago
Physical Therapists
Optometrists
Speech-Language Pathologists
Chiropractors
Occupational Therapists
Podiatrists
Audiologists